Literature DB >> 22461853

Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinoma.

Kazuhide Ishikura1, Toshinari Takamura, Yumie Takeshita, Atsushi Nakagawa, Noriko Imaizumi, Hirofumi Misu, Komei Taji, Kazuo Kasahara, Yukinosuke Oshinoya, Shioto Suzuki, Akishi Ooi, Shuichi Kaneko.   

Abstract

A 41-year-old woman had a general health examination and was diagnosed with a non-functioning adrenocortical carcinoma (ACC). Despite surgery and chemotherapy with mitotane, the ACC progressed with metastases to the lymph nodes, liver and lung. Initially, she developed adrenal insufficiency and was treated with hydrocortisone. As the ACC progressed, it produced superabundant cortisol, resulting in clinically overt Cushing's syndrome. As the liver metastases grew, the patient developed hypoglycaemia with suppression of endogenous insulin secretion. She had to be given large quantities of glucose intravenously to remain normoglycaemic. The serum insulin-like growth factor (IGF)-II/IGF-I ratio had increased to 84. We identified big IGF-II, a primary hormonal mediator of non-islet cell tumour hypoglycaemia (NICTH), in the serum and tumour using western blotting. This is the first case of ACC that showed both Cushing's syndrome and NICTH associated with big IGF-II.

Entities:  

Year:  2010        PMID: 22461853      PMCID: PMC3027795          DOI: 10.1136/bcr.07.2009.2100

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Adrenocortical carcinoma.

Authors:  R D Schulick; M F Brennan
Journal:  World J Urol       Date:  1999-02       Impact factor: 4.226

Review 2.  Adrenal cortical carcinoma.

Authors:  A P Dackiw; J E Lee; R F Gagel; D B Evans
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

3.  The effect of acute insulin-like growth factor-II administration on glucose metabolism in the rat.

Authors:  R Burvin; D LeRoith; H Harel; M Zloczower; M Marbach; E Karnieli
Journal:  Growth Horm IGF Res       Date:  1998-06       Impact factor: 2.372

4.  Hypoglycemia associated with the production of insulin-like growth factor II in adrenocortical carcinoma.

Authors:  T Eguchi; A Tokuyama; Y Tanaka; Y Takahashi; G Kawahara; M Aiba; Y Inishi; H Minowa
Journal:  Intern Med       Date:  2001-08       Impact factor: 1.271

5.  Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.

Authors:  N Hizuka; I Fukuda; K Takano; Y Okubo; K Asakawa-Yasumoto; H Demura
Journal:  Endocr J       Date:  1998-04       Impact factor: 2.349

6.  Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.

Authors:  N Hizuka; I Fukuda; K Takano; K Asakawa-Yasumoto; Y Okubo; H Demura
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.

Authors:  W H Daughaday; M A Emanuele; M H Brooks; A L Barbato; M Kapadia; P Rotwein
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

8.  Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Dafydd G Thomas; Rork Kuick; Michelle Lizyness; David E Misek; Angela L Smith; Donita Sanders; Rima T Aljundi; Paul G Gauger; Norman W Thompson; Jeremy M G Taylor; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

9.  Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice.

Authors:  L Rossetti; N Barzilai; W Chen; T Harris; D Yang; C E Rogler
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

Review 10.  Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.

Authors:  Jan Willem B de Groot; Bart Rikhof; Jaap van Doorn; Henk J G Bilo; Maarten A Alleman; Aafke H Honkoop; Winette T A van der Graaf
Journal:  Endocr Relat Cancer       Date:  2007-12       Impact factor: 5.678

View more
  9 in total

Review 1.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

2.  Biochemical characterization of individual human glycosylated pro-insulin-like growth factor (IGF)-II and big-IGF-II isoforms associated with cancer.

Authors:  Sameer A Greenall; John D Bentley; Lesley A Pearce; Judith A Scoble; Lindsay G Sparrow; Nicola A Bartone; Xiaowen Xiao; Robert C Baxter; Leah J Cosgrove; Timothy E Adams
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

3.  Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical Carcinoma.

Authors:  Natia Murvelashvili; Patricio M Polanco; Sarah M Khorsand; Jorge A Marrero; Liwei Jia; Sasan Mirfakhraee; Tobias Else; Mouhammed Amir Habra; Suzanne Cole; Oksana Hamidi
Journal:  J Endocr Soc       Date:  2022-06-29

Review 4.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

5.  Adrenocortical carcinoma: modern management and evolving treatment strategies.

Authors:  Lucas A McDuffie; Rachel D Aufforth
Journal:  Int J Endocr Oncol       Date:  2016-04-08

6.  Refractory hypoglycemia in a patient with functional adrenal cortical carcinoma.

Authors:  Katia Regina Marchetti; Maria Adelaide Albergaria Pereira; Arnaldo Lichtenstein; Edison Ferreira Paiva
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-11-04

7.  Tumor-Induced Hypoglycemia: An Unusual Case Report and Review of Literature.

Authors:  Basma Abdulhadi; Catherine Anastasopoulou; Patamaporn Lekprasert
Journal:  AACE Clin Case Rep       Date:  2020-12-28

Review 8.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

9.  Nonislet Cell Tumor Hypoglycemia in a Patient with Adrenal Cortical Carcinoma.

Authors:  Se Won Kim; Seung-Eun Lee; Young Lyun Oh; Seokhwi Kim; Sun Hee Park; Jae Hyeon Kim
Journal:  Case Rep Endocrinol       Date:  2016-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.